How PlexusDx Supports a More Personalized Approach GHK-Cu safety considerations extend beyond injection-site reactions to individual tolerance in inflammatory and immune pathways
No gritty taste, no mess, and no flavor additives or artificial sweeteners
GLP-1 receptor agonists have now established a role in the type 2 diabetes management algorithm as the preferred second-line agents in patients with known cardiovascular disease, heart failure, or chronic kidney disease, irrespective of baseline HbA1c
Polet F, Martherus R, Corbet C, Pinto A, Feron O
## **Documentation requirements for J3475** As with any procedure, especially involving injecting drugs into patients, it's important to document the following before you file for a claim that includes this code: - The full name of the personnel who administered the injection + their credentials - The name and address of the facility where the injection was administered - The full name of the patient - The date(s) and time(s) of the drug administrations by injection - The exact dosage throughout the treatment, infusion details, and route - Blood test results showing magnesium levels - Patient records showing a diagnosis of complications that affect magnesium levels and information concerning related symptoms - Patient experience during and after the injection ## **Billing requirements for J3475** Besides the documentation requirements above, please note the following billing requirements for this HCPCS code: - They must reflect the dosage given over the course of the treatment
